| 中文名 | (2b,3a,5a,16b,17b)-17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷 |
|---|---|
| 英文名 | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane |
| 中文别名 |
雄甾-3,17-二醇,2-(4-吗啉基)-16-(1-吡咯烷基)-,17-醋酸酯,(2B,3A,5A,16B,17B)-(9CI)
(2Β,3Α,5Α,16Β,17Β)-17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷 (2Β,3Α,16Β,17Β)-2(4-吗啡啉)-16-(1-四氢吡咯基)-5Α-雄甾-3.醇-17乙酸酯 17-乙酰氧基-3-羟基-2-(4-吗啉基)-16-(1-吡咯烷基)雄甾烷 罗库溴铵中间体八 罗库溴铵中间体LK-8 罗库溴铵中间体 E 罗库溴铵中间体(LK-8) |
| 英文别名 |
RocuroniuM BroMide InterMediate VIII
(2β,3α,5α,16β,17β)-3-Hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstan-17-yl acetate Androstane-3,17-diol, 2-(4-morpholinyl)-16-(1-pyrrolidinyl)-, 17-acetate, (2β,3α,5α,16β,17β)- (2β,3α,5α,16β,17β)-3-Hydroxy-2-(morpholin-4-yl)-16-(pyrrolidin-1-yl)androstan-17-yl acetate (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 574.1±50.0 °C at 760 mmHg |
| 分子式 | C29H48N2O4 |
| 分子量 | 488.702 |
| 闪点 | 301.0±30.1 °C |
| 精确质量 | 488.361420 |
| PSA | 62.24000 |
| LogP | 3.80 |
| 蒸汽压 | 0.0±3.6 mmHg at 25°C |
| 折射率 | 1.574 |
| 储存条件 | 2-8°C,干燥密封 |
| 海关编码 | 2942000000 |
|---|
|
~71%
119302-24-8 |
| 文献:Mendez, Juana Araceli; De La Mora, Marco A.; Rodriguez, Angel A.; Barragan, Efrain; Herrera, Hugo; Guillen, Alejandro Patent: US2007/117975 A1, 2007 ; Location in patent: Page/Page column 15 ; |
|
~92%
119302-24-8 |
| 文献:GLAND PHARMA LIMITED Patent: WO2009/16648 A2, 2009 ; Location in patent: Page/Page column 8-9 ; |
|
~21%
119302-24-8 |
| 文献:US2005/159398 A1, ; Page/Page column 8 ; |
|
~%
119302-24-8 |
| 文献:US2005/159398 A1, ; Page/Page column 8 ; |
|
~%
119302-24-8
详细
|
| 文献:US2007/117975 A1, ; Page/Page column 16 ; |
| 上游产品 4 | |
|---|---|
| 下游产品 0 | |
| 海关编码 | 2942000000 |
|---|